GAIL GROS TURNER
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family MORGAN CITY, LA NPI 1255045985
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family LA ABBVIE INC. All categories
General Payments — all program years on this page
$2,297.46
- Category: General Payments
- Program years: PY2023–2024
- Record count: 134
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $840.15 across 51 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $840.15 | 51 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $138.69 | 9 |
| PFIZER INC. | $82.23 | 5 |
| GlaxoSmithKline, LLC. | $51.17 | 3 |
| Merck Sharp & Dohme Corporation | $48.12 | 3 |
| Phathom Pharmaceuticals, Inc. | $43.75 | 3 |
| Sumitomo Pharma America, Inc. | $43.18 | 2 |
| Otsuka America Pharmaceutical, Inc. | $42.59 | 2 |
| Janssen Pharmaceuticals, Inc | $39.52 | 2 |
| Novo Nordisk AS | $38.57 | 2 |
| Astellas Pharma US Inc | $37.35 | 2 |
| ITI, Inc. | $37.29 | 2 |
| Acerta Pharma LLC | $36.76 | 2 |
| TOLMAR, INC. | $34.97 | 2 |
| Lilly USA, LLC | $31.11 | 2 |
| Corium, Inc. | $24.84 | 3 |
| Seqirus USA Inc | $18.17 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $16.40 | 1 |
| Esperion Therapeutics, Inc. | $16.12 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.47 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.22 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.15 | 1 |
| Amgen Inc. | $13.48 | 1 |
By program year
Records — PY2024 (51)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.